Lebogang Katata

656 total citations
10 papers, 498 citations indexed

About

Lebogang Katata is a scholar working on Pharmaceutical Science, Biomaterials and Infectious Diseases. According to data from OpenAlex, Lebogang Katata has authored 10 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmaceutical Science, 4 papers in Biomaterials and 3 papers in Infectious Diseases. Recurrent topics in Lebogang Katata's work include Advanced Drug Delivery Systems (6 papers), Nanoparticle-Based Drug Delivery (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Lebogang Katata is often cited by papers focused on Advanced Drug Delivery Systems (6 papers), Nanoparticle-Based Drug Delivery (4 papers) and Drug Solubulity and Delivery Systems (3 papers). Lebogang Katata collaborates with scholars based in South Africa, Argentina and Israel. Lebogang Katata's co-authors include Lonji Kalombo, Hulda Swai, J.A. Verschoor, Boitumelo Semete‐Makokotlela, Yolandy Lemmer, Christián Höcht, Diego A. Chiappetta, Alejandro Sosnik, A.M. Crouch and Vemu Nagaraju and has published in prestigious journals such as Analytica Chimica Acta, Drug Discovery Today and Toxicology and Applied Pharmacology.

In The Last Decade

Lebogang Katata

10 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lebogang Katata South Africa 6 218 177 131 104 73 10 498
Boitumelo Semete‐Makokotlela South Africa 11 245 1.1× 211 1.2× 173 1.3× 121 1.2× 85 1.2× 24 673
Bharath Raja Guru India 11 219 1.0× 180 1.0× 286 2.2× 132 1.3× 57 0.8× 24 773
Valamla Bhavana India 16 226 1.0× 216 1.2× 160 1.2× 151 1.5× 43 0.6× 27 712
Mahira Zeeshan Pakistan 15 213 1.0× 206 1.2× 170 1.3× 145 1.4× 75 1.0× 21 675
XiuLing Zheng China 11 380 1.7× 210 1.2× 130 1.0× 121 1.2× 43 0.6× 12 767
Murtada A. Oshi South Korea 9 174 0.8× 218 1.2× 96 0.7× 90 0.9× 49 0.7× 15 531
Gitu Pandey India 15 194 0.9× 130 0.7× 173 1.3× 160 1.5× 61 0.8× 19 566
Veronika Mikušová Slovakia 8 197 0.9× 152 0.9× 116 0.9× 94 0.9× 65 0.9× 19 502
Farshad Ramazani Netherlands 11 242 1.1× 306 1.7× 126 1.0× 175 1.7× 73 1.0× 13 696
Morteza Azhdarzadeh Iran 14 304 1.4× 163 0.9× 264 2.0× 226 2.2× 149 2.0× 21 771

Countries citing papers authored by Lebogang Katata

Since Specialization
Citations

This map shows the geographic impact of Lebogang Katata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lebogang Katata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lebogang Katata more than expected).

Fields of papers citing papers by Lebogang Katata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lebogang Katata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lebogang Katata. The network helps show where Lebogang Katata may publish in the future.

Co-authorship network of co-authors of Lebogang Katata

This figure shows the co-authorship network connecting the top 25 collaborators of Lebogang Katata. A scholar is included among the top collaborators of Lebogang Katata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lebogang Katata. Lebogang Katata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Katata, Lebogang, et al.. (2013). Nanoencapsulation of water-soluble drug, lamivudine, using a double emulsion spray-drying technique for improving HIV treatment. Journal of Nanoparticle Research. 15(11). 19 indexed citations
2.
Katata, Lebogang, Lonji Kalombo, Diego A. Chiappetta, et al.. (2013). Enhanced Oral Bioavailability of The Antiretroviral Efavirenz Encapsulated in Poly(Epsilon-Caprolactone) Nanoparticles by A Spray-Drying Method. Nanomedicine. 9(12). 1821–1833. 41 indexed citations
3.
Katata, Lebogang, et al.. (2012). Design and formulation of nano-sized spray dried efavirenz-part I: influence of formulation parameters. Journal of Nanoparticle Research. 14(11). 13 indexed citations
4.
Semete‐Makokotlela, Boitumelo, Lonji Kalombo, Lebogang Katata, et al.. (2012). Potential of Improving the Treatment of Tuberculosis Through Nanomedicine. Molecular Crystals and Liquid Crystals. 556(1). 317–330. 4 indexed citations
5.
Semete‐Makokotlela, Boitumelo, Yolandy Lemmer, Lonji Kalombo, et al.. (2010). In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems. Nanomedicine Nanotechnology Biology and Medicine. 6(5). 662–671. 328 indexed citations
6.
Kalombo, Lonji, et al.. (2010). In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles. Toxicology and Applied Pharmacology. 249(2). 158–165. 72 indexed citations
7.
Lemmer, Yolandy, Boitumelo Semete‐Makokotlela, Lonji Kalombo, et al.. (2010). Targeted nanodrug delivery systems for the treatment of tuberculosis. Drug Discovery Today. 15(23-24). 1098–1098. 2 indexed citations
8.
Semete‐Makokotlela, Boitumelo, et al.. (2008). Novel nanoparticles for Tuberculosis chemotherapy. 1 indexed citations
10.
Katata, Lebogang, et al.. (2006). A voltammetric study on the speciation and stability constants for iminodisuccinic acid with selected transition metal ions. Chemical Speciation and Bioavailability. 18(3). 85–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026